BV-FAPESP: research projects supported in this Center
CePOF in the Media: news about the Center
The Optics and Photonics Research Center (CePOF) seeks to be an RIDC in which cutting-edge fundamental and applied research in the field of optics and photonics can advance together. The research program consists of cold-matter physics, plasmonics, and biophotonics. In parallel, the Center will advance fundamental knowledge and develop innovative, practical applications.
Turbulence in quantum gases, light-matter entanglement of photons and cold atoms, and optical methods for precision time and frequency metrology define the focus of cold-matter physics. Nanoplasmonics takes optics beyond the diffraction limit, introducing new perspectives for confinement and transport of quantum gases, and for the development of ultrasensitive, rugged biosensors. A modern nanofabrication facility will provide support to all science and technology projects. In biophotonics, the studies focus on the diagnosis and treatment of diseases using purely optical techniques.
The technological innovation that benefits from new scientific insights achieved through basic research will be used to develop new products, establish start-up enterprises, and collaborate with existing companies.
The science dissemination and outreach effort use a 24-hour TV channel and a wide range of activities for all educational levels. Its intent is to create a world-class, internationally recognized Center. The CEPOF will promote international exchange and interaction by recruiting talented students and postdoctoral fellows from all over the world and establishing cooperative agreements with other high-level, globally recognized research centers.
2023-08-09
Photodynamic therapy developed by the Center for Research in Optics and Photonics, which is supported by FAPESP, has been recommended by Brazil’s federal body responsible for including novel healthcare technologies in the national health service.
2022-05-18
Devices that combine laser irradiation, ultrasound and suction help regenerate tissue and treat muscle, joint, skin, neurological and lung damage. Protocols created via business-university partnerships are being tested and can be applied by treatment centers across Brazil.
